Affiliation:
1. Pirogov Russian National Research Medical University; Russian Gerontology Research and Clinical Centre
2. Russian Gerontology Research and Clinical Centre
Abstract
Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) is a common condition in older man. Uroselective a1a-adrenoceptor (AR) antagonists tamsulosin and tamsulosin modified release (OCAS) are the most frequently prescribed medications for the men with LUTS due to BPH. Both tamsulosin and tamsulosin OCAS improve the patients disease-specific quality of life, reduce IPSS by approximately 30–40% and increase Qmax by approximately 20– 25%. The high selectivity of tamsulosin to α1А-adrenoceptor and slow release system OCAS provide a minimal vasodilating effect and correspondingly low risks of falls. These benefits are important in the treatment of LUTS in older men.
Publisher
Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology
Subject
General Materials Science
Reference20 articles.
1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic
2. hyperplasia with age. J Urol 1984; № 132 (3): 474-479.
3. Jacobsen SJ, Girman CJ, Lieber MM Natural history hyperplasia. Urology. 2001;58 (6 Suppl 1):5–16.
4. Raymond Rosen, Jens Altwein, Peter Boyle, Roger S Kirby, B Lukacs, Eric Meuleman, Michael P O’Leary, Paolo Puppo, Chris Robertson, Francois Giuliano, Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7), European Urology, Volume 44, Issue 6, 2003, Pages 637-649,
5. Аденома простаты. Урология. Национальное руководство. Ред. Н.А. Лопаткин. М.: Гэотар-Медиа, 2009; с. 852-889.